video
<ѻýҕl class="article_title">
MASLD in Diabetes: What Clinicians Should Know
ѻýҕl>
"There is a significant interplay between type 2 diabetes and MASLD," explains Sobia Laique, MD, of Cleveland Clinic. Thorough screening is important to identify at-risk MASH in patients with diabetes.(3:23)
video
<ѻýҕl class="article_title">
MASLD Nomenclature: Why the Change?
ѻýҕl>
<ѻýҕl class="article_title">
Lean MASH Patients Face Higher Mortality and Worse Outcomes
ѻýҕl>
These data confirm that lean patients with MASH may be at greater risk of poor health outcomes than non-lean patients with MASH.
<ѻýҕl class="article_title">
MASLD Clinical Outcomes: Numerous, Dangerous
ѻýҕl>
Data on clinical outcomes in MASLD are lacking. This study’s goal was to provide a comprehensive meta-analysis of the longitudinal outcomes associated with MASLD.
<ѻýҕl class="article_title">
In MASLD, Which Serum Lipid-Soluble Micronutrients Heighten Risk?
ѻýҕl>
Serum lipid-soluble micronutrients, such as 25(OH)D and carotenoids, may be protective in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), whereas tocopherols may be associated with pathology, according to this report.
<ѻýҕl class="article_title">
Q&A: Christos S. Mantzoros, MD, PhD, Discusses Steatotic Liver Disease
ѻýҕl>
Christos S. Mantzoros, MD, DSc, PhD, professor of medicine at Harvard Medical School and Boston University, answers our questions about changes in the way we approach steatotic liver disease, formerly known as fatty liver disease.
<ѻýҕl class="article_title">
Screening For MASH: How Accurate Are Non-Invasive Tests?
ѻýҕl>
Investigators reported on the clinical utility of several non-invasive screening methods to reduce the burden of invasive liver tissue sampling in patients at risk of MASH.
<ѻýҕl class="article_title">
Assessing MASH Risk in Older Adults with Diabetes
ѻýҕl>
Patients over age 50 with type 2 diabetes are at particular risk for metabolic dysfunction-associated steatohepatitis, according to the results of this study.
<ѻýҕl class="article_title">
MASLD in Lean Patients: What do We Know?
ѻýҕl>
This systematic review of the literature provides an interpretation of the new criteria related to lean MASLD.